Comparison of the effect of two regimens of metformin and insulin on glucose tolerance test
Phase 3
Completed
- Conditions
- Gestational Diabetes.Gestational diabetes mellitus in pregnancyO24.41
- Registration Number
- IRCT20140317017035N5
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Single-pregnancy
Gestational age 20-34 weeks
FBS is higher than 100 mg/dL
Age range 18 to 40 years
Exclusion Criteria
Diagnosis of pre-pregnancy diabetes, presence of metabolic disorders in the patient Need to start treatment with insulin in oral treatment patients
Dissatisfied to cooperate in the study
Metabolic disorder in the patient
Gestational Hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control of serum glucose level in pregnant women with gestational diabetes mellitus. Timepoint: On average checked twice at week 36. Method of measurement: Oral Glucose Tolerance Test.;Blood sugar levels. Timepoint: 1 hour after birth. Method of measurement: Glucometer.
- Secondary Outcome Measures
Name Time Method eonate weight. Timepoint: After birth. Method of measurement: scale.;Apgar score. Timepoint: First and fifth minutes after birth. Method of measurement: Apgar score scale.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie metformin's synergistic effects with insulin in gestational diabetes mellitus (GDM)?
How does combination therapy of metformin and insulin compare to insulin monotherapy in glycemic control for GDM patients?
Are there specific biomarkers that predict differential response to metformin plus insulin versus insulin alone in GDM management?
What adverse events are associated with metformin-insulin combination therapy in pregnant women with GDM, and how are they managed?
How do metformin and insulin compare to other antidiabetic agents like sulfonylureas in managing O24.41 gestational diabetes?